| Biological Sciences | 2021-2025 | 109 | CN 42 | 99.90 |
| Medical and Health Sciences | 2021-2025 | 763 | CN 75 | 99.83 |
| Cancer Research | Lifetime | 175 | CN 10 | 99.02 |
| Nephrology | Lifetime | 804 | CN 24 | 87.46 |
| Molecular Biology | 2021-2025 | 51 | CN 25 | 99.80 |
| Cancer Research | 2021-2025 | 13 | CN 6 | 99.60 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 187 | CN 30 | 98.59 |
| Surgery | 2021-2025 | 725 | CN 66 | 93.64 |
| Nephrology | 2021-2025 | 186 | CN 18 | 91.36 |
| Psychiatry and Mental health | 2021-2025 | 336 | CN 14 | 91.29 |
| Oncology | 2021-2025 | 757 | CN 88 | 87.77 |
| Immunology | 2021-2025 | 506 | CN 113 | 85.63 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 522 | CN 19 | 82.55 |
| Cancer-related molecular mechanisms research | Lifetime | 68 | CN 24 | 99.57 |
| Circular RNAs in diseases | Lifetime | 31 | CN 14 | 99.58 |
| MicroRNA in disease regulation | Lifetime | 85 | CN 22 | 99.52 |
| Extracellular vesicles in disease | Lifetime | 113 | CN 25 | 98.68 |
| Ferroptosis and cancer prognosis | Lifetime | 202 | CN 88 | 97.43 |
| RNA modifications and cancer | Lifetime | 817 | CN 104 | 98.47 |
| Cancer Mechanisms and Therapy | Lifetime | 457 | CN 68 | 95.49 |
| Tumors and Oncological Cases | Lifetime | 936 | CN 16 | 92.39 |
| Cancer-related molecular mechanisms research | 2021-2025 | 23 | CN 16 | 99.70 |
| MicroRNA in disease regulation | 2021-2025 | 15 | CN 10 | 99.68 |
| Circular RNAs in diseases | 2021-2025 | 9 | CN 5 | 99.62 |
| Extracellular vesicles in disease | 2021-2025 | 14 | CN 10 | 99.38 |
| Epigenetics and DNA Methylation | 2021-2025 | 59 | CN 28 | 98.39 |
| RNA modifications and cancer | 2021-2025 | 145 | CN 96 | 98.47 |
| Ferroptosis and cancer prognosis | 2021-2025 | 159 | CN 124 | 97.30 |
| Cancer-related gene regulation | 2021-2025 | 142 | CN 94 | 92.92 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 271 | CN 89 | 92.75 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 598 | CN 259 | 89.50 |
| Dialysis and Renal Disease Management | 2021-2025 | 504 | CN 39 | 91.71 |
| Cancer Cells and Metastasis | 2021-2025 | 643 | CN 130 | 87.02 |
| Acute Kidney Injury Research | 2021-2025 | 504 | CN 130 | 84.14 |
| Cancer Mechanisms and Therapy | 2021-2025 | 543 | CN 228 | 79.11 |
| Kruppel-like factors research | 2021-2025 | 181 | CN 58 | 78.77 |
| Hormonal and reproductive studies | 2021-2025 | 624 | CN 55 | 80.38 |
| Breast Lesions and Carcinomas | 2021-2025 | 652 | CN 73 | 78.76 |
| Sexual function and dysfunction studies | 2021-2025 | 643 | CN 82 | 79.21 |
| Kidney Stones and Urolithiasis Treatments | 2021-2025 | 727 | CN 138 | 79.91 |
